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ABSTRACT
Reduced levels of survival motor neuron (SMN) protein lead to a neuromuscular disease called spinal muscular atrophy (SMA).
Animal models of SMA recapitulate many aspects of the human disease, including locomotion and viability defects, but have
thus far failed to uncover the causative link between a lack of SMN protein and neuromuscular dysfunction. While SMN is
known to assemble small nuclear ribonucleoproteins (snRNPs) that catalyze pre-mRNA splicing, it remains unclear whether
disruptions in splicing are etiologic for SMA. To investigate this issue, we carried out RNA deep-sequencing (RNA-seq) on age-
matched Drosophila Smn-null and wild-type larvae. Comparison of genome-wide mRNA expression profiles with publicly
available data sets revealed the timing of a developmental arrest in the Smn mutants. Furthermore, genome-wide differences in
splicing between wild-type and Smn animals did not correlate with changes in mRNA levels. Specifically, we found that mRNA
levels of genes that contain minor introns vary more over developmental time than they do between wild-type and Smn
mutants. An analysis of reads mapping to minor-class intron–exon junctions revealed only small changes in the splicing of
minor introns in Smn larvae, within the normal fluctuations that occur throughout development. In contrast, Smn mutants
displayed a prominent increase in levels of stress-responsive transcripts, indicating a systemic response to the developmental
arrest induced by loss of SMN protein. These findings not only provide important mechanistic insight into the developmental
arrest displayed by Smn mutants, but also argue against a minor-intron-dependent etiology for SMA.
Keywords: minor intron; splicing; snRNP; survival motor neuron; spinal muscular atrophy; RNA-sequencing; transcriptome;
Drosophila insulin-like peptide 8; dILP8; stress signaling pathways
INTRODUCTION
The survival motor neuron protein (SMN) functions as part
of a large multimeric complex in the assembly of Sm-class
small nuclear ribonucleoproteins (snRNPs), core compo-
nents of the spliceosome (Fischer et al. 2011). Loss-of-func-
tion mutations in human SMN1 cause spinal muscular
atrophy (SMA), a genetic disorder characterized by motor
neuron degeneration, atrophy of proximal muscles, and sym-
metrical paralysis (Burghes and Beattie 2009). Although the
severity of SMA clearly depends on SMN protein levels
(Lorson et al. 2010), the etiologic connection between loss
of SMN expression and disease pathology remains unknown.
A central issue is how loss of SMN expression manifests
as a neuromuscular disorder. Although SMN may well have
snRNP-independent functions (Carrel et al. 2006; Burghes
and Beattie 2009), the role of SMN in snRNP assembly and
splicing continues to be a central focus of much of the re-
search into SMA etiology (Winkler et al. 2005; Gabanella
et al. 2007; Zhang et al. 2008; Bäumer et al. 2009; Workman
et al. 2009). Nevertheless, it remains unclear how disruption
of a ubiquitously required process leads to a neuromuscular
phenotype.
SMN assembles Sm-class snRNPs for both the major (U2-
type) and minor (U12-type) spliceosomes. Minor-class in-
trons are very rare and the cellular abundance of minor spli-
ceosomes is low (Montzka and Steitz 1988; Tarn and Steitz
1996). Moreover, the splicing of U12-type introns is slower
than that of U2-type introns (Patel et al. 2002). Thus, a trac-
table hypothesis posits the existence of a neuromuscular-spe-
cific minor-intron splicing event that is highly sensitive to
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disruptions in snRNP assembly. Testing this hypothesis in
Drosophila models of SMA, two recent reports dispute the
extent to which defects in minor intron splicing may ac-
count for SMA-like phenotypes (Lotti et al. 2012; Praveen
et al. 2012). First, we showed that transgenic expression of
low levels of wild-type dSMN protein could fully rescue larval
motility and viability without fully rescuing snRNA levels
(Praveen et al. 2012). Second, Smn-null animals showed
modest (30%–50%) decreases in the levels of four minor in-
tron-containing transcripts; however, the levels of these four
mRNAs did not correlate with expression of the wild-type
Smn rescue construct (Praveen et al. 2012). This study pro-
vides strong evidence uncoupling the snRNP assembly func-
tions of dSMN from the organismal motility and viability
defects.
In contrast, Lotti et al. (2012) analyzed Smn-null larvae at
later stages of development and reported similar decreases in
snRNA levels, along with defects in splicing of seven minor
intron-containing transcripts. Among these seven genes,
two of them (CG11839 and CG33108) overlapped with the
four described by Praveen et al. (2012). In addition, Lotti
et al. (2012) reported that two other transcripts, CG16941
and CG8408 (Stasimon), exhibited minor intron retention.
The investigators further demonstrated that transgenic ex-
pression of Stasimon, either in all neurons or specifically in
cholinergic neurons, rescued an electrophysiological defect
at larval neuromuscular junctions in Smn mutants (Lotti
et al. 2012). However, Stasimon expression failed to rescue
motor rhythm, locomotion, or organismal viability (Lotti
et al. 2012). These data support a role for Smn in the proper
functioning of motor circuits (Imlach et al. 2012), but do not
provide convincing evidence for aberrant splicing of minor
introns as the molecular basis for SMA.
The situation described above is very similar to two recent
studies using a mouse model of severe SMA. Using microar-
ray analyses in late symptomatic mice, Zhang et al. (2008) re-
ported widespread tissue-specific changes in the splicing of
both minor- and major-class introns. Subsequently, Bäumer
et al. (2009) showed that these changes were limited to late-
symptomatic mice; both pre- and early-symptomatic SMA
mice do not display such splicing defects. Thus, the observed
differences in splicing are likely a downstream consequence
of severe SMN loss (Bäumer et al. 2009). Because microarray
(Zhang et al. 2008; Bäumer et al. 2009) and quantitative
(q)RT-PCR experiments (Lotti et al. 2012; Praveen et al.
2012) have significant drawbacks, we sought a more sensi-
tive and robust approach to address whether Smn loss causes
changes in pre-mRNA splicing and mRNA abundance in
Drosophila.
RESULTS AND DISCUSSION
Todetermine if dSMNdepletion disrupts pre-mRNA splicing
and mRNA levels, we performed high-throughput RNA-se-
quencing (RNA-seq) on poly(A)-selected RNA from age-
matched Smn-null and wild-type (Oregon R, Ore-R) larvae.
Two biological replicates were sequenced per genotype.
Each sample consisted of RNA from 40–60 larvae isolated at
an age (72–76 h post–egg laying)when they display locomotor
defects but have not yet begun to die (Praveen et al. 2012). As
expected, RNA-seq confirmed the absence of Smn transcripts
in the Smn-null larvae (Fig. 1A).
To determine whether gene expression is changed in Smn
mutants, the Tophat (Trapnell et al. 2009) and Cufflinks/
Cuffdiff (Trapnell et al. 2010) analysis pipeline was used to
map sequenced cDNA reads and to quantify genome-wide
changes in gene expression (Trapnell et al. 2012). Measure-
ments of mRNA levels are denoted as fragments per kilobase
per million reads mapped (FPKM) (see Supplemental Table
S1). Analysis of gene expression differences between Smn-
null and wild-type animals uncovered several transcripts
whose levels changed significantly but did not appear to be
differentially spliced. A large number of genes up-regulated
in the Smn-null mutants encode proteins from cuticle pro-
tein families, specifically the CPR (cuticular protein with
Rebers and Riddiford consensus domain) and Tweedle fam-
ilies (Supplemental Table S1). These transcripts have been
FIGURE 1. Developmental arrest phenotype of Smn mutants. (A)
University of California Santa Cruz (UCSC) genome browser snapshot
of mapped RNA-seq reads at the Smn locus from wild-type and Smn
mutant animals. Track counts in the wild-type (Ore-R) bedGraph file
were normalized using the median of track counts from the Smnmutant
bedGraph files. (B) Dendrogram of wild-type (Ore-R) and Smnmutants
compared with the developmental transcriptome data from second in-
star (L2), third instar 12 h post-molt (L312hr), third instar puffstage 1
to 2 with dark blue, bromophenol blue fed guts (L3P1_2), third instar
puffstage 3 to 6 with light blue guts (L3P3_6), and the last larval puff-
stage with clear guts (L3P7_9) (Graveley et al. 2011). Wild-type and
Smn mutant RNA-seq data are each the average of two biological sam-
ples. Dendrogram line segments correspond to Jensen-Shannon dis-
tances (Trapnell et al. 2010). (C) Venn diagrams of DEXSeq, MISO,
and Cuffdiff analysis of differences between wild-type and Smn mutant
RNA-seq results. For comparison, DEXSeq and MISO results were con-
verted into a nonredundant list of genes that overlap the noted differenc-
es in exon usage and alternative splicing events, respectively.
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shown to be elevated during the early third instar develop-
mental stage (Graveley et al. 2011), and their overabundance
in Smn-null versus wild-type animals of equivalent age is
consistent with a previously reported developmental delay
phenotype caused by loss of dSMN (Shpargel et al. 2009).
To further characterize this developmental phenotype, to-
tal RNA-seq reads from Smn-null and wild-type animals
were compared with the modENCODE Drosophila develop-
mental transcriptome data (Graveley et al. 2011). This com-
parison clustered the Smn-null mutants with the late second
and early third instar stages (Fig. 1B, L2 to L312hr). Notably,
the transcript profile from our control animals more closely
matched a later third instar stage (Fig. 1, L3P1_2). Genome-
wide transcriptome profiling thus provides molecular evi-
dence for a developmental arrest in the Smn-null animals.
Because wild-type transcript levels vary over developmental
time, it is necessary to compare RNA levels in Smn-null an-
imals with those of younger wild-type controls. Due to the
developmental arrest in the mutants, this stipulation is espe-
cially important for the later larval stages.
Although Cufflinks was useful in obtaining FPKMs to
quantify mRNA abundance, its ability to unambiguously dif-
ferentiate between mRNA isoforms is more limited. To ad-
dress this limitation and to determine if dSMN depletion
leads to changes in pre-mRNA splicing, we used two addi-
tional bioinformatics packages, DEXSeq (Anders et al.
2012) and MISO (Katz et al. 2010; see Supplemental Tables
S2–S6). Put simply, DEXSeq is a statistical algorithm that
tests for differential exon usage given a set of annotated
mRNA exons. MISO is an algorithm that uses a mixture-
of-isoforms probabilistic model to test for differences in a
supplied set of annotated alternative
splicing events. Using relatively relaxed
significance cutoffs, both DEXSeq (P-
value < 0.05) and MISO (Bayes factor >
100) uncovered more splicing changes
between Smn mutants and wild type
than those that occur over a similar
span of development (L2 thru L3P1_2).
Indeed, DEXSeq and MISO identified
2153 and 2484 differences between Smn
and wild type, respectively, whereas a
similar analysis of the modENCODE
data found 951 and 877 splicing changes,
respectively.
However, these alternative splicing
events did not correlate with changes in
mRNA abundance, as measured by Cuff-
diff. This lack of correlation persists
even when one limits the analysis to the
most significant events, as determined
by both methods. As shown in Figure
1C, Cuffdiff was used to measure mRNA
abundance in 179 differentially spliced
genes identified by both DEXSeq (P-val-
ue < 0.01) andMISO (Bayes factor > 105). Of these 179 genes,
which are the least likely to be false positives, the FPKMs of
fewer than one quarter of them (40) changed by more than
twofold. Furthermore, only four of these genes changed by
less than twofold over larval development (Fig. 1C). Thus,
the levels of most of these 179 mRNAs are within the normal
fluctuations that occur over developmental time, and none of
them, including the final four, were significantly different as
determined by Cuffdiff (q-value < 0.05, where the q-value is
a P-value adjusted for false discovery rate) (Trapnell et al.
2012).
Recent reports specifically dispute the extent to which
dSMN depletion affects minor intron splicing and levels of
minor-intron-containing transcripts (Lotti et al. 2012;
Praveen et al. 2012). Consistent with our previously pub-
lished qRT-PCR results (Praveen et al. 2012), RNA-seq con-
firmed that levels of minor-intron-containing mRNAs are
largely unaffected by loss of Smn (Fig. 2A). Of the seven
mRNAs identified by Lotti et al. (2012) whose expression
was reduced in Smnmutants, none were significantly reduced
in our RNA-seq data set (Fig. 2A). To determine if devel-
opmental fluctuations in minor-intron-containing mRNA
levels could account for observed differences between our re-
sults (Praveen et al. 2012) and those of Lotti et al. (2012), the
levels of these transcripts in the Smn-null and wild-type
RNA-seq data were compared with the modENCODE devel-
opmental data (Graveley et al. 2011). As shown in Figure
2B, the levels of minor-intron-containing mRNAs varied
more over developmental time than they did between wild-
type and Smnmutants. Thus, previously noted qRT-PCR dis-
crepancies between Praveen et al. (2012) and Lotti et al.
FIGURE 2. Relatively unaltered minor-intron-containing mRNA levels in Smn mutants. (A)
Pairwise comparison of Cuffdiff FPKM levels between wild type and the Smnmutant. FPKM lev-
els were normalized to the wild type, and error bars indicate standard deviation. (B) Heatmap
comparison of minor-intron-containing mRNA FPKM levels over development and between
wild type and the Smnmutant. Heatmap colors were rescaled for each row, and rows were man-
ually reordered based on trends in gene expression over development. CG33108 was excluded
here because Cufflinks’ FPMK analysis did not distinguish between CG33108 and LSm3.
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(2012) may reflect differences in larval staging, rather than
Smn-dependent decreases.
Having detected only low-level changes in mRNA expres-
sion in Smnmutants, it was not clear what effect these subtle
changes might have on protein levels. To assess the outcome
of dSMN depletion on a protein encoded by a minor-intron-
containing mRNA, we performed Western blotting for
Prohibitin 2 (Phb2) in larval lysates from wild type, Smnmu-
tants, and U6atac mutants. We chose phb2 because it is the
only Drosophila minor-intron-containing gene that is ex-
pressed at reasonably high levels (Fig. 3A), and its splicing
is known to be disrupted in U6atac mutants (Pessa et al.
2010; Praveen et al. 2012). As shown in Figure 3B, Phb2 pro-
tein levels were unaffected in Smn mutants but decreased
as expected in U6atac hypomorphs. Although Smn mutant
phb2 mRNA levels were unaltered in our current RNA-seq
analysis (Fig. 2A), our previous qRT-PCR experiments
(Praveen et al. 2012) showed a roughly twofold decrease in
phb2 transcript levels in Smn-null mutants. These data sug-
gest that small changes (twofold or less) in minor-intron-
containing mRNAs may fall within the experimental noise
of both qRT-PCR and RNA-seq methodologies, and that
such small changes are unlikely to significantly alter cognate
protein levels.
Irrespective of changes in mRNA or protein levels, disrup-
tions in splicing may have other negative phenotypic conse-
quences, such as the production of nonfunctional mRNAs
or proteins. In their study, Lotti et al. (2012) highlighted a
single-minor-intron-containing mRNA, Stasimon, and its
role in a specific electrophysiological phenotype. In addition
to a slight decrease in Stasimon mRNA levels, they noted an
increase in Stasimon minor intron retention in Smn mutants
(Lotti et al. 2012). To quantify the degree of minor intron re-
tention in Stasimon and other minor-intron-containing tran-
scripts, we designed a custom Perl script to count specific
reads spanning exon–exon and intron–
exon junctions (Fig. 4A; Supplemental
Table S7). We found that Stasimon and
three other minor-intron-containing
mRNAs exhibited significant (P-value <
0.01) increases in minor intron retention
in the Smnmutants (Fig. 4; Supplemental
Table S7). However, intron retention for
these genes is also readily detectable in
the wild-type samples, including those
from the modENCODE project (Fig.
4B; Supplemental Table S7; Graveley
et al. 2011). Strikingly, the levels of intron
retention for these genes fluctuate during
larval development (Supplemental Table
S7). In particular, retention of the minor
intron in Stasimon was greatest at the
L312hr time point in the modENCODE
data set (Fig. 4B). Because Smn mutants
are developmentally arrested at this par-
ticular stage, the elevated intron retention identified by our
analysis, and noted by Lotti et al. (2012), appears to be a con-
sequence of the developmental arrest and thus not a result of
dSMN depletion.
To identify genes whose differences in expression level
could not be accounted for by developmental fluctuations,
we searched within our Cuffdiff list of significantly altered
transcripts (Supplemental Table S1) for differences that
were inconsistent with and/or exceeded normal develop-
mental changes. Using Gene Ontology (GO) enrichment
analysis, we noted a large number of stress responsive trans-
cripts that were up-regulated in the Smn mutants (Fig. 5A;
FIGURE 3. Prohibitin 2 protein levels unchanged in Smnmutants. (A) UCSC browser snapshot
of normalized RNA-seq tracks at the Prohibitin 2 gene locus. (B) Western blot of Prohibitin 2
(Phb2). Phb2 levels were analyzed in protein lysates from age-matched wild-type (Ore-R),
Smn mutant (Smn), and U6atac mutant (U6atac) larvae as well as a later-stage wandering
wild-type larva (Ore-R late L3). The anti-prohibitin antibody recognizes the minor-intron-con-
taining PHB2, upper band, and PHB1, lower band, which doesn’t contain a known U12-type
minor intron. The Drosophilamitochondrial ATP synthase bellwether (BLW) served as a loading
control.
FIGURE 4. Increase in StasimonmRNAminor intron retention in Smn
mutants and early in the third instar larval stage. (A) UCSC browser
snapshot of normalized RNA-seq tracks at the Stasimon gene locus
and diagram of junction spanning reads used to measure intron reten-
tion. (Gray lines and numbers) Exon–intron junction reads; (black lines
and numbers) exon–exon junction reads. (Gray brackets and arrows in
gene model) Minor intron locations. (B) StasimonmRNAminor intron
retention levels as a percentage of exon–intron (intron) junction span-
ning reads over total junction spanning reads between wild type, mu-
tant, and over the developmental time from L2 to L3P7_9. Actual
junction-spanning read counts and calculations are also provided in
Supplemental Table S7. For comparison with our paired-end data, we
used the Celniker paired-end modENCODE developmental data for
this analysis (Supplemental Table S7).
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Supplemental Table S1). Unlike the CPR and Tweedle gene
families mentioned above, the expression of these stress re-
sponse genes was inconsistent with the timing of the Smn
mutant developmental arrest and exceeded normal develop-
mental fluctuations. Thus, changes in levels of these mRNAs
appear to be a consequence of dSMN depletion. The Toll,
Imd (Immune deficiency), JNK (c-Jun N-terminal kinase),
and JAK-STAT (Janus kinase–signal transducer and activator
of transcription) signaling pathways regulate expression of
these transcripts in response to infectious and noninfectious
stresses (Leclerc and Reichhart 2004; Biteau et al. 2011; Teix-
eira 2012). For example, the mRNAs for AttacinA (AttA) and
Drosocin (Dro) encode antimicrobial peptides that are nor-
mally increased in response to septic injury, but their expres-
sion has also been linked to noninfectious stressors (Sano
et al. 2005; Tsuzuki et al. 2012).
At least two additional signaling pathways have been linked
to the noninfectious induction of antimicrobial peptides, the
IIS (insulin/insulin-like growth factor) (Becker et al. 2010;
Karpac et al. 2011), and the GBP (growth blocking peptide)
growth-factor signaling pathways (Tsuzuki et al. 2012).
Transcripts for traditional cytokines associated with these
pathways, such as dILP1-5 (Insulin-like peptides 1–5),
dILP7 and GBP (CG15917) are largely unaltered in Smnmu-
tants, whereas dIILP6 showed a nearly threefold decrease
(Supplemental Table S1). Perhaps most notable was the dra-
matic increase in expression of dILP8 (Insulin-like peptide
8), a recently discovered cytokine (Fig. 5B). Secretion of
dILP8 by damaged or slow-growing imaginal discs was
shown to coordinate organismal growth with developmental
progression (Colombani et al. 2012; Garelli et al. 2012). In
particular, dILP8 was shown to block the transition from lar-
val to pupal stages (Colombani et al. 2012; Garelli et al. 2012).
Interestingly, we find that Smn-null mutant larvae have
either very small or nonexistent imaginal discs (data not
shown). Therefore, we submit that up-regulation of dILP8
contributes to the pupariation failure observed in Smn-null
mutants.
In summary, Smn-null larvae (harvested at 72–76 h post–
egg laying) display significant locomotor deficits (Shpargel
et al. 2009; Praveen et al. 2012), but do not show appreciable
genome-wide changes inmRNA levels. Based onmorpholog-
ical criteria, we previously concluded that Smn-null mutants
are developmentally delayed (Shpargel et al. 2009). Here, we
show by transcriptome profiling that Smn mutants display a
molecular signature indicating a profound developmental ar-
rest during the early third larval instar. Consistent with this
notion, Smn-null larvae never display the wandering behav-
ior that is characteristic of the late third instar, despite the
fact that a small fraction of these animals live for several
weeks (Praveen et al. 2012). Proper staging of experimental
and control animals is critical to anymeaningful comparison.
Because Lotti et al. (2012) used RNA isolated fromwandering
third instar larvae (108 ± 12 h post–egg laying) as controls,
their qRT-PCR data may appear to show that Smn depletion
negatively affects certain transcripts, when in actuality it is
due to a combination of both developmental fluctuation
and normal biological noise.
Transcriptome profiling reveals that Smn mutants display
an increase in stress-responsive transcripts that may be a di-
rect or indirect consequence of SMN loss. However, the role
of these transcripts in the etiology of SMA-like phenotypes is
not clear. The developmental arrest may be a downstream
consequence of the inability of Smn-null larvae to feed prop-
erly. With this caveat in mind, the RNA-seq data provide ev-
idence for the activation of stress signaling pathways that
could represent an important systemic response to dSMN
depletion. The activation of cellular stress pathways was pre-
viously observed in a mouse embryonic stem (ES) cell model
of SMA and in spinal cord tissues from which these ES cells
were derived (Wu et al. 2011). Thus, activation of stress-
response pathways may be a conserved feature of SMA.
Neuronal overexpression of certain antimicrobial peptides,
which are known stress signaling targets, was recently shown
to cause neurodegeneration in Drosophila (Cao et al. 2013).
Taken together, these observations suggest that the activation
of cellular stress signaling pathways in Smnmutants is an im-
portant pathophysiological consequence of SMN depletion
that is relevant for modeling SMA.
Overall, the observed developmental arrest complicates
determination of cause and effect in the pathophysiology of
Smn mutants. Both fruit fly and mouse models of severe
SMA display neuromuscular deficits that are detectable early
in the disease course, whereas splicing defects are only appar-
ent later on (Zhang et al. 2008; Bäumer et al. 2009; Lotti et al.
2012; Praveen et al. 2012). Our RNA-seq data reveal several
differences in pre-mRNA splicing between wild-type and
FIGURE 5. Increased stress-responsive target genes in Smn mutants.
(A) Stress-responsive transcripts that were significantly increased in
the Smn mutants expressed here as fold increase above wild-type levels
(from average Cufdiff FPKM values) (Supplemental Table S1). (B)
UCSC browser snapshot of normalized RNA-seq tracks at the dILP8
gene locus.
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Smn animals. However, these splicing differences do not cor-
relate with changes in mRNA levels. The impact, if any, of
these small changes on the organism’s neurophysiology re-
mains to be elucidated. Results presented here cannot ex-
clude the important possibility that tissue- and cell-specific
splicing events below the current level of detection might
be causative for SMA. Future studies of mRNA splicing and
abundance in isolated cells and tissues may uncover a more
direct link between SMN depletion, splicing, and SMA-like
phenotypes. Nevertheless, the results presented here raise
serious doubt as to the validity of conclusions reached by oth-
ers regarding the connection between splicing deficiencies
and motor circuit dysfunction (Roselli and Caroni 2012).
Clearly, additional studies will be needed in order to fully elu-
cidate the molecular etiology of SMA.
MATERIALS AND METHODS
Drosophila stocks
Fly stocks were cultured as in Praveen et al. (2012). Briefly, larvae
were cultured on molasses and agar at room temperature (24°C ±
1°C). The wild-type allele was Oregon-R. Smn-null animals were
trans-heterozygous for an SmnX7 microdeletion allele (Chang et al.
2008) and an isogenized SmnD (f01109) transposon allele from
the Exelixis collection at the Harvard Medical School (Rajendra
et al. 2007).
RNA-seq and bioinformatic analysis
RNAwas isolated from 74 ± 2-h-old wild-type and Smnmutant lar-
vae by homogenization in TRIzol (Invitrogen), according to the
manufacturer’s protocol. RNA was DNased with Amplification
Grade DNase I (Invitrogen). A TruSeq RNA Sample Preparation
Kit v2 (Illumina) was used for: poly(A) enrichment, barcoding for
multiplexing, and cDNA library preparation. Paired end (2 × 50) se-





Smn mutant, EG007_ACTGAT_L005_R1_001.fastq EG007_ACTG
AT_L005_R2_001.fastq and EG008_ATTCCT_L005_R1_001.
fastq EG008_ATTCCT_L005_R2_001.fastq.
TopHat and Cufflinks were used to quantify and compare mRNA
FPKM levels, according to the bioinformatic pipeline from Trapnell
et al. (2012). We used RStudio (http://www.rstudio.org/) to inter-
face with the R statistical suite (http://www.r-project.org), and the
R-based cummeRbund package (http://compbio.mit.edu/cumme
Rbund/) was used as a graphical interface with the Cufflink’s
Cuffdiff output. DEXSeq (Anders et al. 2012) and MISO (Katz
et al. 2010) were used to measure changes in exon usage and anno-
tated alternative splicing events, respectively. For developmental
comparison, all publicly available RNA-seq data from Graveley
et al. (2011) (http://www.modencode.org/) from L2 to L3 puff stage
7–9 were downloaded from the NCBI Sequence Read Archive
(SRA) and converted to fastq format with the SRA toolkit. The
heatmap was generated with the Heatplus R package from biocon-
ductor (http://www.bioconductor.org). Reads mapping to exon–in-
tron junctions of U12 introns were extracted from SAM files
generated by Tophat and quantified using a custom Perl script.
P-values were generated using the Fisher’s exact test.
Western blotting
Western analysis was performed using standard protocols, accord-
ing to the methods of Praveen et al. (2012). Briefly, larval protein ly-
sates were prepared by crushing the animals in lysis buffer (50 mM
Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40) with
1× protease inhibitor cocktail (Invitrogen) and clearing the lysate by
centrifugation. The anti-prohibitin 2 antibody (H-80; Santa Cruz
Biotechnology) was used at a 1:100 dilution. The anti-mitochondrial
ATP synthase antibody, ATP5A [15H4C4] (Abcam)—which recog-
nizes Drosophila bellwether (BLW), was used as a loading control at
a 1:1000 dilution.
DATA DEPOSITION
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus (Edgar et al. 2002) and are acces-
sible through GEO Series accession number GSE49587 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49587).
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Supplemental material is available for this article.
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